THE TAKEOVER battle for drug firm Goldshield was believed to be in its final stages yesterday.<br /><br />It now seems unlikely that someone will table a better bid than the £162m being offered by AIT, the investment vehicle of former chief executive Ajit Patel. <br /><br />Goldshield management, who own 9.62 per cent of the firm, on Monday confirmed they were trying to gatecrash AIT’s 440p-a-share offer. <br /><br />But the group’s independent directors revealed that the management team has already made several failed offers for the group since January. <br /><br />The management, including current chief executive Rakesh Patel, have yet to come up with a higher bid than AIT’s – despite criticising the 440p-a-share offer as “too low”. <br /><br />Analysts said they believed the battle to be over now, with AIT assuming control of the group shortly.